Do you have the same question? Follow this Question
Oct 23, 2025 - 11:03 AM
We’ve provided several answers to questions related to Epclusa (Sofosbuvir/Velpatasvir) , see some other helpful Q&A related to this product.
Question: What are the common side effects of sofosbuvir?
Answer: Common side effects of sofosbuvir include headache, fatigue, and nausea. Some people may also experience insomnia, irritability, or anemia. Most side effects are mild, but you should contact your doctor if they become severe or persistent.
Question: What is the ATC code for this medication?
Answer: The ATC code is J05AP55. The Anatomical Therapeutic Chemical (ATC) classification system is used for drug classification, which assists healthcare providers in identifying and prescribing medications appropriately.
Question: What is the protein binding percentage of sofosbuvir?
Answer: Sofosbuvir has a protein binding of 61–65%. Protein binding affects how much of the drug is available to work in the body, with moderate binding balancing efficacy and duration of action.
Question: What is the bioavailability of sofosbuvir in this medication?
Answer: The bioavailability of sofosbuvir is 92%. High bioavailability means that a large proportion of the drug reaches the bloodstream, which increases its effectiveness in treating hepatitis C.
View all Epclusa (Sofosbuvir/Velpatasvir) Questions & Answers
